Composition for treating acute brain injury or neurodegenerative disease, method of making, and use thereof
AssigneeMorehouse School of Medicine
InventorTiandong LENG
Life of this patent
Estimating the term…
Abstract
Methods and compositions that inhibit CYP46A pathways are provided for the prevention and treatment of neurodegenerative disease and brain injury, including i.e. Alzheimer's disease, tanopathies, cerebral ischemia and/or brain trauma. Compositions of the application are voriconazole, or analog compounds of voriconazole, or variants of voriconazole with a generic substitution in its chemical structure.
Claims20
A method of treating a neurodegenerative disease in a subject in need thereof comprising
- administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising voriconazole, or analog compound of voriconazole, or variant of voriconazole with a generic substitution in its chemical structure, and a pharmaceutically acceptable carrier.
A method of treating Alzheimer's disease in a subject in need thereof comprising
- administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising voriconazole, or analog compound of voriconazole, or variant of voriconazole with a generic substitution in its chemical structure, and a pharmaceutically acceptable carrier.
A method of treating acute brain injury in a subject in need thereof, comprising:
- administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising voriconazole, or analog compound of voriconazole, or variant of voriconazole with a generic substitution in its chemical structure, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.